These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2418898

  • 1. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
    Dover GJ, Humphries RK, Moore JG, Ley TJ, Young NS, Charache S, Nienhuis AW.
    Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
    [Abstract] [Full Text] [Related]

  • 2. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R, Lima CS, Grotto HZ.
    J Clin Lab Anal; 2003 Mar; 17(2):66-72. PubMed ID: 12640630
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G.
    N Engl J Med; 1985 Dec 19; 313(25):1571-5. PubMed ID: 2415821
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis.
    Letvin NL, Linch DC, Beardsley GP, McIntyre KW, Miller BA, Nathan DG.
    J Clin Invest; 1985 Jun 19; 75(6):1999-2005. PubMed ID: 2409112
    [Abstract] [Full Text] [Related]

  • 6. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
    Koshy M, Dorn L, Bressler L, Molokie R, Lavelle D, Talischy N, Hoffman R, van Overveld W, DeSimone J.
    Blood; 2000 Oct 01; 96(7):2379-84. PubMed ID: 11001887
    [Abstract] [Full Text] [Related]

  • 7. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987 Oct 01; 251():455-66. PubMed ID: 2448813
    [Abstract] [Full Text] [Related]

  • 8. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov 01; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 9. 5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens.
    Dover GJ, Charache S, Boyer SH, Vogelsang G, Moyer M.
    Blood; 1985 Sep 01; 66(3):527-32. PubMed ID: 2411310
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH.
    Semin Hematol; 1997 Jul 01; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
    Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.
    Blood; 1996 Feb 01; 87(3):887-92. PubMed ID: 8562958
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia.
    Charache S, Dover GJ, Moyer MA, Moore JW.
    Blood; 1987 Jan 01; 69(1):109-16. PubMed ID: 2431728
    [Abstract] [Full Text] [Related]

  • 19. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA, al-Momen A, Warsy AS, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F.
    Acta Haematol; 1995 Jan 01; 93(2-4):57-61. PubMed ID: 7543719
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ, Humphries RK, Young N, Ley T, Boyer S, Charache S, Nienhuis A.
    Prog Clin Biol Res; 1985 Jan 01; 191():447-54. PubMed ID: 2413480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.